TY - JOUR T1 - Gene Expression Changes in a Chemoresistant Model with Human Esophageal Cancer Xenografts Using cDNA Microarray JF - Anticancer Research JO - Anticancer Res SP - 1163 LP - 1168 VL - 29 IS - 4 AU - TAKAHIRO YOSHIDA AU - TAKANORI MIYOSHI AU - JUN-ICHI SEIKE AU - HIROMICHI YAMAI AU - HIROKAZU TAKECHI AU - YASUHIRO YUASA AU - AKIRA TANGOKU Y1 - 2009/04/01 UR - http://ar.iiarjournals.org/content/29/4/1163.abstract N2 - Background: 5-Fluorouracil (5-FU) and cisplatin combined chemotherapy (FP) is commonly used for esophageal cancer. Acquired resistance needs to be overcome to improve the chemotherapeutic effect. Materials and Methods: The FP-resistant xenograft model using severe combined immunodeficient (SCID) mice was established as an acquired resistance model. RNA was extracted pretreatment, at the onset of the anticancer effect, during the most effective, and regrowth period in the FP administration group and during the mid-progressive period and the far advanced period in the control group. A microarray was applied to explore gene expression changes. Results: The data set containing up-regulated genes in the regrowth period was uploaded into Ingenuity Pathway Analysis. The expression change profiles suggested that activation of not only 5-FU- and cisplatin-specific genes, but also the Phosphoinositide 3-kinase (PI3K)/AKT signal were associated with FP resistance. Conclusion: A xenograft model using SCID mice with esophageal cancer cells would monitor gene changes during treatment and regrowth. ER -